SecBot SecBot
PRESS-RELEASE ·Filed May 4, 2026

NIVF

NewGenIVF Group Limited
NEUTRAL
Impact 4/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

The profit is from a one-time accounting gain, not operational performance. Traders should look for sustainable revenue from IVF, real estate, and digital assets in future filings. The micro-cap stock may react to the asset growth but lack of core earnings growth limits upside.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
NIVF ▼ -83.16% at T+60d
NEUTRAL call -83.16% · α vs SPY -85.01% · entry $5.07 → $0.8539
Entry = T+0 close
May 4, 2026
via day close
T+1d
-13.61%
call -13.61% · α -14.41%
$4.38
settled 6mo ago
T+5d
-31.95%
call -31.95% · α -34.92%
$3.45
settled 6mo ago
T+20d
-45.21%
call -45.21% · α -51.00%
$2.78
settled 5mo ago
T+60d
-83.16%
call -83.16% · α -85.01%
$0.8539
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

NewGenIVF reported fiscal year 2025 results with total assets of $32.7 million and net profit of $9.9 million, primarily from a bargain purchase gain on acquisitions. The profit is non-recurring and core revenue/earnings are not disclosed, making the report neutral for the micro-cap stock.

Key Facts

  • Total assets as of Dec 31, 2025: $32.7 million vs $3.6 million in 2024
  • Net profit attributable to shareholders: $9.9 million, mainly from bargain purchase gain of $19.2 million on Nodexus and Microsort acquisitions
  • Authorized $2 million share repurchase program in November 2025

Financial Impact

Net profit of $9.9 million is non-recurring (bargain purchase gain); no recurring revenue or EPS disclosed.

total assetsnet profit

Risk Factors

  • Profit is non-recurring (bargain purchase gain), not indicative of ongoing operations
  • No revenue or EPS figures provided, making valuation speculative
  • Micro-cap stock with high volatility (as seen in prior reports)

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3286706
22 reports for NIVF
Performance horizon
75% Hit rate @ T+1 9 of 12 directional calls Went positive at some point 12 of 12 best @ T+60▲ +98.51%Jul 31, 2026
Filters
Rows
Reports for NIVF — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 4/10
$0.1884 $0.1489▼ −20.97%▼ −19.79%$1.15 (+510.40%)
Oct 7, 2026
20d ago
6-K
BEARISH ★ 7/10
$0.0811 $0.0721▲ +11.10%▲ +11.70%$1.15 (−1318.00%)
Oct 7, 2026
20d ago
6-K
NEUTRAL ★ 3/10
$0.1060 $0.0811▼ −23.49%▼ −23.07%$1.15 (+984.91%)
Oct 6, 2026
21d ago
SC 13D/A
NEUTRAL ★ 3/10
$0.0987 $0.1060▲ +7.40%▲ +7.64%$1.15 (+1065.15%)
Oct 5, 2026
22d ago
6-K
BEARISH ★ 6/10
$0.1100 $0.0987▲ +10.27%▲ +10.82%$1.15 (−945.45%)
Sep 30, 2026
27d ago
Press Release
BEARISH ★ 6/10
$0.1680 $0.1010▲ +39.88%▲ +40.06%$1.15 (−584.52%)
Sep 30, 2026
27d ago
424B4
BEARISH ★ 8/10
$5.38 $3.23▲ +39.88%▲ +40.06%$1.15 (+78.61%)
Sep 29, 2026
28d ago
EFFECT
BEARISH ★ 7/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.15 (−1497.22%)
Sep 28, 2026
28d ago
Press Release
BEARISH ★ 6/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.15 (−1497.22%)
Sep 2, 2026
7w ago
Insider Cluster
MIXED ★ 6/10
$1.21 $1.18▼ −2.48%▼ −3.53%$1.15 (−4.96%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026